Drospirenone: a Novel Progestogen with Antimineralocorticoid and Antiandrogenic Activity

@article{Muhn1995DrospirenoneAN,
  title={Drospirenone: a Novel Progestogen with Antimineralocorticoid and Antiandrogenic Activity},
  author={P. Muhn and U. Fuhrmann and K. Fritzemeier and R. Krattenmacher and E. Schillinger},
  journal={Annals of the New York Academy of Sciences},
  year={1995},
  volume={761}
}
Drospirenone (ZK 30595; 6 beta, 7 beta, 15 beta, 16 beta-dimethylen-3-oxo-17 alpha-pregn-4-ene-21, 17-carbolactone) is a novel progestogen under clinical development. Drospirenone is characterized by an innovative pharmacodynamic profile which is very closely related to that of progesterone. Potential applications include oral contraception, hormone replacement therapy and treatment of hormonal disorders. The pharmacological properties of drospirenone were investigated in vitro by receptor… Expand
Drospirenone, a progestogen with antimineralocorticoid properties: a short review
  • W. Oelkers
  • Medicine
  • Molecular and Cellular Endocrinology
  • 2004
Drospirenone and its antialdosterone properties
Drospirenone in combination with estrogens: for contraception and hormone replacement therapy
  • W. Oelkers
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2005
Pharmacology of different progestogens: the special case of drospirenone
  • R. Sitruk-Ware
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2005
PII: S0010-7824(00)00133-5
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 35 REFERENCES
Progestogens with antimineralocorticoid activity.
Anti-androgens in a castrated mouse test
The metabolic effects of progesterone in man.
...
1
2
3
4
...